| Emerging technologies for use in the study, diagnosis, and treatment of patients with COVID-19 M Tsikala Vafea, E Atalla, J Georgakas, F Shehadeh, EK Mylona, ... Cellular and molecular bioengineering 13, 249-257, 2020 | 157 | 2020 |
| Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis M Tsikala-Vafea, N Belani, K Vieira, H Khan, D Farmakiotis International Journal of Infectious Diseases 106, 142-154, 2021 | 56 | 2021 |
| Integrase strand transfer inhibitors and the emergence of immune reconstitution inflammatory syndrome (IRIS) M Psichogiou, D Basoulis, M Tsikala-Vafea, S Vlachos, CJ Kapelios, ... Current HIV research 15 (6), 405-410, 2017 | 39 | 2017 |
| Clinical presentation, course, and risk factors associated with mortality in a severe outbreak of COVID-19 in Rhode Island, USA, April–June 2020 E Atalla, R Zhang, F Shehadeh, EK Mylona, M Tsikala-Vafea, S Kalagara, ... Pathogens 10 (1), 8, 2020 | 31 | 2020 |
| Chest CT findings in asymptomatic cases with COVID-19: a systematic review and meta-analysis MT Vafea, E Atalla, M Kalligeros, EK Mylona, F Shehadeh, E Mylonakis Clinical radiology 75 (11), 876. e33-876. e39, 2020 | 29 | 2020 |
| Prognostic benefit of surgical management of renal cell carcinoma invading the inferior vena cava A Mastoraki, S Mastoraki, M Tsikala-Vafea, IS Papanikolaou, A Lazaris, ... Indian journal of surgical oncology 8, 14-18, 2017 | 17 | 2017 |
| Mortality in mechanically ventilated patients with COVID-19: a systematic review M Tsikala Vafea, R Zhang, M Kalligeros, EK Mylona, F Shehadeh, ... Expert Review of Medical Devices 18 (5), 457-471, 2021 | 14 | 2021 |
| A pilot trial of thymalfasin (thymosin-α-1) to treat hospitalized patients with hypoxemia and lymphocytopenia due to coronavirus disease 2019 infection F Shehadeh, G Benitez, EK Mylona, QL Tran, M Tsikala-Vafea, E Atalla, ... The Journal of Infectious Diseases 227 (2), 226-235, 2023 | 13 | 2023 |
| Clinical outcomes of adult patients hospitalized with COVID-19 after vaccination M Kalligeros, F Shehadeh, EK Mylona, M Kaczynski, S Kalagara, E Atalla, ... Tropical Medicine and Infectious Disease 6 (4), 175, 2021 | 12 | 2021 |
| Bloodstream infections by gram‐negative bacteria in kidney transplant patients: Incidence, risk factors, and outcome M Tsikala‐Vafea, D Basoulis, I Pavlopoulou, M Darema, J Deliolanis, ... Transplant Infectious Disease 22 (6), e13442, 2020 | 8 | 2020 |
| Impact of influenza infection among adult and pediatric populations with hematologic malignancy and hematopoietic stem cell transplant: a systematic review and meta-analysis E Atalla, M Kalligeros, EK Mylona, M Tsikala-Vafea, F Shehadeh, ... Clinical Therapeutics 43 (5), e66-e85, 2021 | 7 | 2021 |
| Fatal mucormycosis and aspergillosis in an atypical host: what do we know about mixed invasive mold infections? M Tsikala-Vafea, W Cao, AJ Olszewski, JE Donahue, D Farmakiotis Case Reports in Infectious Diseases 2020, 2020 | 6 | 2020 |
| Spondylodiscitis associated with major abdominal surgical intervention: challenging diagnostic and therapeutic modalities A Mastoraki, S Mastoraki, IS Papanikolaou, M Tsikala-Vafea, V Tsigou, ... Indian Journal of Surgical Oncology 8, 274-278, 2017 | 1 | 2017 |
| Factors Associated With Enrollment into Inpatient Coronavirus Disease 2019 Randomized Controlled Trials: A Cross-sectional Analysis M Kaczynski, G Benitez, EK Mylona, QL Tran, E Atalla, M Tsikala-Vafea, ... Open Forum Infectious Diseases 10 (5), ofad197, 2023 | | 2023 |
| Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19 G Benitez, F Shehadeh, EK Mylona, QL Tran, M Tsikala-Vafea, E Atalla, ... International Immunopharmacology 116, 109831, 2023 | | 2023 |
| Corrigendum to ‘Worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis’ M Tsikala-Vafea, D Farmakiotis International Journal of Infectious Diseases 113, 34-35, 2021 | | 2021 |
| 222. Bloodstream Infections by Gram (−) Bacteria in Kidney Transplant Patients: Risk Factors, Incidence and Outcome; Bloodstream Infections by Gram (−) Bacteria in Kidney … MT Vafea, D Basoulis, M Darema, I Deliolanis, I Pavlopoulou, ... Open Forum Infectious Diseases 6, 2019 | | 2019 |
